MANFREDI, Andreina Teresa
 Distribuzione geografica
Continente #
NA - Nord America 25.537
EU - Europa 14.409
AS - Asia 9.900
SA - Sud America 1.478
Continente sconosciuto - Info sul continente non disponibili 482
AF - Africa 318
OC - Oceania 101
Totale 52.225
Nazione #
US - Stati Uniti d'America 24.690
IT - Italia 7.406
SG - Singapore 2.976
GB - Regno Unito 2.459
CN - Cina 2.401
BR - Brasile 1.094
HK - Hong Kong 1.076
SE - Svezia 979
VN - Vietnam 971
DE - Germania 631
FR - Francia 576
FI - Finlandia 531
BD - Bangladesh 522
RU - Federazione Russa 425
CA - Canada 388
UA - Ucraina 385
TR - Turchia 381
KR - Corea 276
IN - India 265
JP - Giappone 231
NL - Olanda 215
ID - Indonesia 206
MX - Messico 199
IE - Irlanda 167
BG - Bulgaria 161
AR - Argentina 141
AU - Australia 93
ZA - Sudafrica 90
PL - Polonia 78
IQ - Iraq 77
PK - Pakistan 76
AE - Emirati Arabi Uniti 64
EC - Ecuador 59
TN - Tunisia 59
ES - Italia 57
MY - Malesia 51
LT - Lituania 50
IL - Israele 49
CO - Colombia 46
CH - Svizzera 43
CL - Cile 43
PH - Filippine 39
TT - Trinidad e Tobago 37
BE - Belgio 36
EG - Egitto 35
SA - Arabia Saudita 34
IR - Iran 33
CR - Costa Rica 31
HN - Honduras 31
MA - Marocco 31
VE - Venezuela 30
PE - Perù 29
AT - Austria 28
SC - Seychelles 27
RO - Romania 24
GT - Guatemala 23
NP - Nepal 23
UZ - Uzbekistan 23
TH - Thailandia 22
HU - Ungheria 21
JM - Giamaica 21
JO - Giordania 21
SV - El Salvador 21
BZ - Belize 20
DZ - Algeria 20
KE - Kenya 19
DK - Danimarca 18
NI - Nicaragua 17
PT - Portogallo 17
EU - Europa 16
TW - Taiwan 16
PY - Paraguay 14
GP - Guadalupe 13
PR - Porto Rico 13
BO - Bolivia 12
DO - Repubblica Dominicana 12
RS - Serbia 12
AZ - Azerbaigian 11
CW - ???statistics.table.value.countryCode.CW??? 11
EE - Estonia 10
HR - Croazia 9
CZ - Repubblica Ceca 8
GR - Grecia 8
MD - Moldavia 8
NZ - Nuova Zelanda 8
AL - Albania 7
ET - Etiopia 7
LV - Lettonia 7
OM - Oman 7
KG - Kirghizistan 6
LB - Libano 6
LU - Lussemburgo 6
NO - Norvegia 6
PA - Panama 6
SI - Slovenia 6
UY - Uruguay 6
BB - Barbados 5
BY - Bielorussia 5
CY - Cipro 5
KZ - Kazakistan 5
Totale 51.689
Città #
Ashburn 2.993
Santa Clara 2.112
Singapore 2.034
Fairfield 1.724
Southend 1.515
San Jose 1.178
Hong Kong 1.044
Woodbridge 941
Chandler 917
Council Bluffs 830
Houston 770
Chicago 690
Wilmington 640
Hefei 619
Seattle 611
Los Angeles 581
Milan 578
Jacksonville 572
Cambridge 535
Ann Arbor 531
Rome 514
Nyköping 513
London 451
Beijing 426
Helsinki 408
Dearborn 387
The Dalles 348
New York 346
Ho Chi Minh City 292
Salt Lake City 277
Modena 250
Seoul 237
Hanoi 234
San Diego 184
Dallas 183
Izmir 181
São Paulo 157
Sofia 152
Princeton 151
Buffalo 149
Jakarta 135
Bologna 134
Florence 132
Naples 132
Redwood City 132
Tampa 132
Dublin 130
Lauterbourg 122
Elk Grove Village 120
Toronto 116
Columbus 115
Eugene 113
Shanghai 113
Bari 112
Palermo 112
Tokyo 102
Moscow 100
Frankfurt am Main 98
Catania 86
Phoenix 80
Bremen 77
Boardman 74
Falls Church 72
Genoa 72
Turin 72
Orem 70
Mexico City 67
Verona 66
Munich 62
North Bergen 61
Atlanta 60
Des Moines 57
Sterling 57
Brooklyn 55
Lancaster 55
Da Nang 54
Montreal 54
Denver 50
Miami 50
Padova 50
Chennai 47
Perth 47
San Francisco 47
Guangzhou 44
Cagliari 42
Johannesburg 41
Manchester 40
Warsaw 40
Mumbai 38
Parma 36
Amsterdam 35
Paris 35
Detroit 34
Dulles 34
Ankara 33
Las Vegas 33
Ottawa 33
Haiphong 32
Kansas City 31
Philadelphia 31
Totale 31.559
Nome #
INTERSTIZIOPATIA POLMONARE NON CLASSIFICABILE O SECONDARIA A CONNETTIVITE INDIFFERENZIATA. IMPORTANZA E DIFFICOLTÀ DI UNA DIAGNOSI DIFFERENZIALE. 3.908
Epidemiology and management of interstitial lung disease in ANCA-associated vasculitis 1.429
TIPIZZAZIONE CLINICA DELLA SINDROME ANTISINTETASICA: CONFRONTO TRA PAZIENTI ANTI JO-1 POSITIVI E NEGATIVI 1.384
ALTERAZIONI CAPILLAROSCOPICHE IN CORSO DI DERMATOMIOSITE E SCLEROSI SISTEMICA; VERSO L’INDIVIDUAZIONE DI PATTERN SPECIFICI 1.000
La capillaroscopia in reumatologia. Lesioni elementari e metodi di scoring 858
Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients. 517
Radiologic classification of usual interstitial pneumonia in rheumatoid arthritis-related interstitial lung disease: correlations with clinical, serological and demographic features of disease 509
Evoluzione dello CSURI (Capillaroscopic Skin Ulcer Risk Index) in pazienti affetti da sclerosi sistemica in terapia con antiendotelina-1 e prostanoidi 498
Oxycodone in the Long-Term Treatment of Chronic Pain Related to Scleroderma Skin Ulcers. 494
Bronchoalveolar lavage and response to cyclophosphamide in scleroderma alveolitis. 466
Analysis of pulmonary sounds for the diagnosis of interstitial lung diseases secondary to rheumatoid arthritis 447
Diagnostic accuracy of a velcro sound detector (VECTOR) for interstitial lung disease in rheumatoid arthritis patients: The InSPIRAtE validation study (INterStitial pneumonia in rheumatoid ArThritis with an electronic device) 436
Effect of treatment with iloprost with or without bosentan on nailfold videocapillaroscopic alterations in patients with systemic sclerosis 410
Nailfold Videocapillaroscopy Alterations in Dermatomyositis and Systemic Sclerosis: Toward Identification of a Specific Pattern 409
Acute exacerbation of interstitial lung disease associated with rheumatic disease 405
Systemic sclerosis and cryoglobulinemia: our experience with overlapping syndrome of scleroderma and severe cryoglobulinemic vasculitis and review of the literature. 404
Cardiac Involvement in Systemic Vasculitis 401
Radiological thymus alterations in systemic sclerosis: our experience and a review of the literature. 399
Recommendations for the management of pulmonary fungal infections in patients with rheumatoid arthritis 396
D-penicillamine in the treatment of eosinophilic fasciitis: case reports and review of the literature. 395
Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis 395
Current treatment of hepatitis C-associated rheumatic diseases. 387
CXCL10 (α) and CCL2 (β) chemokines in systemic sclerosis - A longitudinal study 387
Efficacia di terapia con immunoassorbimento con proteina A dello stafilococco e talidomide in un caso di dermatomiosite refrattaria. 386
Therapeutic options after treatment failure in rheumatoid arthritis or spondyloarthritides 380
Systemic sclerosis evolution of disease pathomorphosis and survival. Our experience on Italian patients' population and review of the literature 378
Carotidynia Possibly due to Localized Vasculitis in a Patient with Latent Mycobacterium tuberculosis Infection. 373
Combination Therapy with Nintedanib and Sarilumab for the Management of Rheumatoid Arthritis Related Interstitial Lung Disease 370
NEW PERSPECTIVES IN DIAGNOSIS OF INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. VALIDATION STUDY OF AN ELECTRONIC STETHOSCOPE AND AD HOC SOFTWARE FOR DETECTION OF PULMONARY CRACKLES 369
Scleroderma digital ulcers complicated by infection with fecal pathogens. 366
Aortic pulse wave velocity measurement in systemic sclerosis patients. 365
Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvement 358
Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature 355
Circulating CXCL11 and CXCL10 are increased in hepatitis C-associated cryoglobulinemia in the presence of autoimmune thyroiditis. 352
CAPILLAROSCOPIC SKIN ULCER RISK INDEX (CSURI) IN SYSTEMIC SCLEROSIS: RESULTS FROM AN ITALIAN MULTICENTER VALIDATION STUDY 351
Staphylococcus protein A-based extracorporeal immunoadsorption and thalidomide in the treatment of skin manifestation of dermatomyositis: a case report. 347
Recombinant human erythropoietin stimulates vasculogenesis and wound healing in a patient with systemic sclerosis complicated by severe skin ulcers. 343
CORRELATION OF A QUANTITATIVE VIDEOCAPILLAROSCOPIC SCORE WITH THE DEVELOPMENT OF DIGITAL SKIN ULCERS IN SCLERODERMA PATIENTS 342
Serum 25-OH vitamin D levels in systemic sclerosis: analysis of 140 patients and review of the literature 342
Capillaroscopic Skin Ulcers Risk Index (CSURI) calculated with different videocapillaroscopy devices: how its predictive values change 341
Gynaecological Screening for Cervical and Vulvar Malignancies in a Cohort of Systemic Sclerosis Patients: Our Experience and Review of the Literature 338
Nailfold capillaroscopic changes in dermatomyositis and polymyositis 337
Antiendothelial cell antibodies induce apoptosis of bone marrow endothelial progenitors in systemic sclerosis 337
Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature. 337
Efficacy and safety of mycophenolate mofetil in the treatment of rheumatic disease-related interstitial lung disease: a narrative review 336
Platelet gel in the treatment of severe scleroderma skin ulcers. 333
COST ANALYSIS RELATED TO SUBCUTANEOUS IMMUNOGLOBULINS IN PATIENTS WITH INFLAMMATORY MYOPATHIES AND IMMUNE-MEDIATED CHRONIC NEUROPATHIES. RESULTS OF AN OPEN LABEL STUDY 331
HRCT Patterns Of Usual Interstitial Pneumonia In Rheumatoid Lung 331
Cryoglobulinemic vasculitis and skin ulcers. Our therapeutic strategy and review of the literature 322
Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baseline 320
Interstitial pneumonia with autoimmune features: A single center prospective follow-up study 320
Modulatory effects of peroxisome proliferator-activated receptor-γ on CXCR3 chemokines 316
Safety of Abatacept in Italian Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Multicenter Retrospective Study 316
Predictive role of capillaroscopic skin ulcer risk index in systematic sclerosis: a multicentre validation study 313
Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease: Our interdisciplinary rheumatology-pneumology experience, and review of the literature 313
Prevalence and evolution of scleroderma pattern at nailfold videocapillaroscopy in systemic sclerosis patients: Clinical and prognostic implications 311
Antifibrotic drugs in connective tissue disease-related interstitial lung disease (CTD-ILD): from mechanistic insights to therapeutic applications 310
Cardiovascular risk and prostanoids in systemic sclerosis 305
AB1157 VALIDATION OF VECTOR (VELCRO CRACKLES DETECTOR) FOR THE DIAGNOSIS OF INTERSTITIAL LUNG DISEASE IN PATIENTS WITH CONNECTIVE TISSUE DISEASES 303
Prediction risk chart for scleroderma digital ulcers: A composite predictive model based on capillaroscopic, demographic and clinico-serological parameters 297
Timing of onset affects arthritis presentation pattern in antisyntethase syndrome 294
Correlation of a quantitative videocapillaroscopic score with the development of digital skin ulcers in scleroderma patients 294
UNCLASSIFIABLE INTERSTITIAL LUNG DISEASE OR UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE? A CHALLENGING DIFFERENTIAL DIAGNOSIS 294
High circulating chemokines (C-X-C motif) ligand 9, and (C-X-C motif) ligand 11, in hepatitis C-associated cryoglobulinemia. 291
Classification of pulmonary sounds through deep learning for the diagnosis of interstitial lung diseases secondary to connective tissue diseases 286
Scleroderma Digital Ulcers Complicated by Infection with Fecal Pathogens. 285
Mixed cryoglobulinemia syndrome: where are we going to? 279
DIGITAL NECROSIS IN SYSTEMIC SCLEROSIS NOT ONLY A MICROVASCULAR DISEASE: A CASE REPORT 278
Therapeutic Options for the Treatment of Interstitial Lung Disease Related to Connective Tissue Diseases. A Narrative Review 277
Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicenter retrospective study 276
Measuring microangiopathy abnormalities in systemic sclerosis patients: the role of capillaroscopy-based scoring models 274
INTERSTITIAL LUNG DISEASE IS ASSOCIATED TO INFECTIONS OF LOWER RESPIRATORY TRACT IN IMMUNOCOMPROMISED RHEUMATOID ARTHRITIS PATIENTS 274
Neurologic Complications Associated with Sjögren's Disease: Case Reports and Modern Pathogenic Dilemma 273
The performance of the GAP model in patients with rheumatoid arthritis associated interstitial lung disease 272
Osteomyelitis complicating scleroderma digital ulcers. 270
SEVERE VITAMIN D DEFICIENCY IN SYSTEMIC SCLEROSIS 268
Lung and Breast Cancer in Systemic Sclerosis: Correlations with the Disease's Features 266
Italian consensus recommendations for the management of hepatitis C infection in patients with rheumatoid arthritis 266
Chemokine (CXC motif) ligand 9 serum levels in mixed cryoglobulinemia are associated with circulating levels of IFN-γ and TNF-α 265
RHEUMATOID ARTHRITIS RELATED INTERSTITIAL LUNG DISEASE. RADIOLOGICAL PATTERNS AND CORRELATIONS WITH CLINICAL, SEROLOGICAL AND DEMOGRAPHIC FEATURES OF DISEASE 264
Scleroderma skin ulcers definition, classification and treatment strategies our experience and review of the literature 261
Predicting Mortality in Patients with Rheumatoid Arthritis Related Interstitial Lung Disease: Expanding The GAP Model 259
Factors Predicting Early Failure of Etanercept in Rheumatoid Arthritis: An Analysis From the Gruppo Italiano di Studio sulla Early Arthritis (Italian Group for the Study of Early Arthritis) Registry 259
Nailfold Capillaroscopy Characteristics of Antisynthetase Syndrome and Possible Clinical Associations: Results of a Multicenter International Study 257
Validation study of predictive value of capillaroscopic skin ulcer risk index (CSURI) in scleroderma patients treated with bosentan 256
AB0472 PRIMARY SJOGREN SYNDROME ASSOCIATED INTERSTITIAL LUNG DISEASE: FEATURES, TREATMENT AND OUTCOME OF A MONOCENTRIC COHORT 256
Trattamento del dolore in reumatologia con oppioidi: nostra esperienza con ossicodone in pazienti con ulcere cutanee vasculitiche. 253
AB0624 SAFETY OF RITUXIMAB BIOSIMILAR FOR THE TREATMENT OF CRYOGLOBULINEMIC VASCULITIS 253
Procedural pain management in the treatment of scleroderma digital ulcers 251
Trattamento con IgIV ad alte dosi in un caso di dermatomiosite con grave disfagia refrattaria alle terapie standard. 247
Efficacy and safety of rituximab in the treatment of connective tissue disease-related interstitial lung disease 247
Valore predittivo di uno score capillaroscopico nei pazienti sclerodermici. 246
Nailfold videocapillaroscopy in antisynthetase syndrome 242
Prise en charge de l'infection par le virus de l'hépatite B chez les patients atteints de polyarthrite rhumatoïde: conférence de consensus italienne [Italian consensus guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis] 242
A new chance to treat rheumatoid arthritis lung fibrosis? 240
Trattamento della fascite eosinofila con D-penicillamina: descrizione di 3 casi. 240
Interstitial lung disease is associated to infections of lower respiratory tract in immunocompromised rheumatoid arthritis patients 240
PAP-TEST FEATURES IN A COHORT OF SYSTEMIC SCLEROSIS PATIENTS 240
NAILFOLD VIDEOCAPILLAROSCOPY FEATURES OF PATIENTS WITH ANTISYNTHETASE SYNDROME 240
Thyroid involvement in hepatitis C - associated mixed cryoglobulinemia 239
Totale 39.392
Categoria #
all - tutte 192.833
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 192.833


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.470 0 0 0 0 170 287 182 196 389 316 512 418
2022/20234.459 457 336 271 316 439 532 264 438 536 204 391 275
2023/20244.240 221 274 279 454 574 346 356 548 153 240 343 452
2024/20258.032 334 198 231 585 1.540 1.135 590 418 821 423 794 963
2025/202615.319 800 516 1.011 2.020 3.042 1.045 1.737 647 1.320 1.171 1.098 912
2026/20275.210 561 1.039 1.090 2.082 438 0 0 0 0 0 0 0
Totale 52.225